Welcome to our dedicated page for BNB Plus SEC filings (Ticker: BNBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BNB Plus Corp. (BNBX) SEC filings page on Stock Titan aggregates the company’s regulatory disclosures, offering investors structured access to its official reports. As a Nasdaq-listed smaller reporting company, BNB Plus files documents that describe its BNB-focused digital asset treasury strategy, capital structure, and ongoing operations in nucleic acid production.
Key filings include registration statements such as the S-1/A, which details the resale of common stock issued in cash and crypto private placements, as well as associated pre-funded warrants, Series E warrants, and warrants issued to placement agents, advisors, and consultants. These documents explain the terms of the securities, potential dilution, and the relationships with institutional investors and strategic partners.
Current reports on Form 8-K provide insight into material events, including shareholder votes at special meetings. For example, BNB Plus has reported stockholder approval of warrant exercisability, increases in authorized common stock, and expansions of its equity incentive plan. Such filings help clarify how the company manages its equity base while pursuing a BNB-based treasury strategy and operating its LineaDNA business.
Through Stock Titan, users can review annual reports on Form 10-K and quarterly reports on Form 10-Q when filed, along with proxy statements and other disclosures that address risk factors, business descriptions, and financial results. AI-powered summaries on the platform are designed to highlight key points from lengthy documents, such as capital structure changes, treasury-related disclosures, and updates on the LineaRx and LineaDNA operations.
Investors can also monitor ownership changes and insider activity through forms like Form 4 when available, gaining additional context on how executives and major holders interact with BNB Plus stock. Together, these filings form the primary regulatory record of the company’s activities.
BNB Plus Corp. reported that on January 15, 2026, Elizabeth M. Schmalz Shaheen resigned from its board of directors, effective immediately. The company stated that her resignation was not due to any disagreement with BNB Plus Corp. regarding its operations, policies, or practices. The filing does not describe any changes to company strategy or operations linked to this departure, indicating this is presented as a routine board change.
BNB Plus Corp. received an amended Schedule 13G/A reporting a passive ownership position in its common stock. Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz together beneficially own 217,840 shares of BNB Plus Corp. common stock, representing 4.9% of the class as of the event date of 12/31/2025.
The filing shows these reporting persons have shared voting and dispositive power over all 217,840 shares, with no sole voting or dispositive power. They certify that the securities were not acquired and are not held for the purpose of changing or influencing control of BNB Plus Corp., indicating a passive investment rather than an activist position.
BNB Plus Corp. is registering up to 18,728,341 shares of common stock for resale by existing investors, mostly shares issued or issuable from recent private placements and related warrants. The company will not receive proceeds from these resale transactions, but could receive cash if investors exercise pre-funded, Series E, placement agent, advisory and consultant warrants, which together could bring in up to $40.7 million at a $3.82 exercise price.
The company has pivoted to a digital asset treasury model focused on BNB, the native cryptocurrency of the Binance ecosystem, using financing proceeds to accumulate BNB and seek yield through staking and decentralized finance opportunities. It also continues to operate LineaRx, which develops cell-free DNA and RNA manufacturing technologies for biotherapeutics and diagnostics.
The filing outlines new strategic agreements, including a five-year digital asset management mandate with Cypress-affiliated entities, long-term advisory and consulting contracts, formation of crypto-focused subsidiaries, and recent BNB purchases that brought total BNB exposure to about 18,830 tokens as of mid-December 2025.
BNB Plus Corp. has filed an amended S-1 to register up to 18,728,341 shares of common stock for resale by existing selling stockholders. The shares include stock already issued in recent private placements and shares underlying multiple series of pre-funded and common warrants held by investors, advisors, the placement agent, and a consultant.
The company will not receive proceeds from stockholder resales, but could receive cash if warrants are exercised, which it plans to use primarily to advance its BNB-focused digital asset treasury strategy and for general corporate purposes. Shares outstanding were 4,365,541 as of December 15, 2025 and would be 20,544,309 if all registered underlying securities are issued. BNB Plus is repositioning around a BNB-based digital asset treasury while continuing to develop its LineaRx DNA and RNA production technologies.
BNB Plus Corp. has transformed into a digital asset treasury company centered on holding and actively managing BNB, the native cryptocurrency of the Binance ecosystem, while continuing to develop its LineaRx synthetic DNA and RNA production platforms for potential sale or licensing. The company raised
To fund this shift, BNB Plus exited DNA tagging and clinical lab testing, closed its ADCL lab, and executed multiple restructurings that reduced headcount by 72% and are projected to cut payroll by about 70% versus the prior year, while incurring one-time severance and impairment charges. The LineaRx business now concentrates on its LineaDNA and LineaIVT technologies for therapeutic DNA and mRNA manufacturing, competing with large established players. As of December 15, 2025, the company had 4,365,541 shares of common stock outstanding and held about 18,830 BNB, including direct holdings and exposure via OBNB trust units, reflecting a significant balance-sheet commitment to BNB amid evolving and uncertain digital asset regulation.
BNB PLUS CORP. reported that its Chief Executive Officer, as an officer of the company, acquired two stock option positions on December 15, 2025.
One is an incentive stock option and the other a non-qualified stock option, each giving the right to buy 42,194 shares of common stock at an exercise price of $2.52 per share, expiring on December 15, 2035. The options were acquired at a price of $0 and are reported as held directly. According to the disclosure, these options vest 25% per quarter, beginning 90 days from the grant date.
BNB Plus Corp reported that its chief financial officer, Beth Jantzen, received equity awards in the form of stock options on 12/15/2025. She was granted an incentive stock option to buy 42,194 shares of common stock and a separate non-qualified stock option to buy 42,194 shares, each with an exercise price of $2.52 per share and an expiration date of 12/15/2035.
The options were granted at a price of $0 for the options themselves, giving her the right, but not the obligation, to purchase BNB Plus Corp common stock at $2.52 in the future. According to the disclosure, the options vest 25% per quarter, beginning 90 days from the grant date, and are held with direct ownership.
BNB Plus Corp. held a special meeting of stockholders on December 12, 2025, where investors approved three capital-related proposals. Stockholders first approved, under Nasdaq Listing Rules 5635(a) and 5635(d), the exercisability of certain pre-funded warrants and common stock purchase warrants, and the issuance of the common shares underlying those securities, which were issued under a securities purchase agreement dated September 29, 2025.
They also approved an amendment to the Certificate of Incorporation to increase authorized common shares from 200,000,000 to 500,000,000, expanding the number of shares the company may issue in the future. In addition, stockholders approved an amendment to the 2020 Equity Incentive Plan to increase the shares reserved for equity awards by 5,000,000. Each proposal received sufficient votes for approval, indicating broad support for the company’s capital and incentive plans.
BNB PLUS CORP. director Joshua Kruger filed an initial Form 3 reporting his ownership in the company. As of the event date of 11/06/2025, he beneficially owns 75,302 shares of common stock directly.
He also holds Series E-1 warrants that are exercisable beginning on 10/03/2025 and expiring on 10/03/2030, covering 75,302 shares of common stock at an exercise price of $3.82 per share, also held directly.
FAQ
What is the current stock price of BNB Plus (BNBX)?
What is the market cap of BNB Plus (BNBX)?
